hit counter
AptarGroup, Inc. (ATR) Stock News Sentiment & Price - Sentifly
ATR - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



AptarGroup, Inc. (ATR)

USA
Packaging & Containers
NYSE
ATR Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
ATR Latest news
Zacks Investment Research
Neutral
AMCR or ATR: Which Is the Better Value Stock Right Now?
2021-11-05 12:58

AMCR vs. ATR: Which Stock Is the Better Value Option?

Business Wire
Neutral
Aptar Named a Global Top 10 Female-Friendly Company by Forbes
2021-11-02 16:05

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Named a Global Top 10 Female-Friendly Company by Forbes

Seeking Alpha
Neutral
AptarGroup Inc. (ATR) CEO Stephan Tanda on Q3 2021 Results - Earnings Call Transcript
2021-10-29 16:33

AptarGroup Inc. (ATR) CEO Stephan Tanda on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Neutral
AptarGroup (ATR) Meets Q3 Earnings Estimates
2021-10-28 19:51

AptarGroup (ATR) delivered earnings and revenue surprises of 0.00% and 0.98%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Benzinga
Neutral
AptarGroup: Q3 Earnings Insights
2021-10-28 17:50

AptarGroup (NYSE:ATR) reported its Q3 earnings results on Thursday, October 28, 2021 at 05:00 PM. Here's what investors need to know about the announcement.

Business Wire
Neutral
Aptar Reports Third Quarter 2021 Results
2021-10-28 17:07

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today reported third quarter results for 2021. Third Quarter 2021 Summary Reported sales grew 9%, primarily driven by double-digit core sales growth in Beauty + Home and Food + Beverage from a combination of price increases and volume growth Core sales (excluding currency effects) increased 8% Pharma sales declined slightly compar

Business Wire
Neutral
First Nasally-Administered Pharmaceutical Treatment for Dry Eye Disease Approved by US FDA with Aptar's Nasal Pump System
2021-10-25 08:30

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today announced that its patented Cartridge Pump System (CPS), designed for the multidose delivery of preserved and non-preserved drug formulations, was recently reviewed by the U.S. FDA as the drug delivery device in the approval of Oyster Point Pharma's TYRVAYA™ (varenicline solution) Nasal Spray 0.03 mg1, the first and only nas

Zacks Investment Research
Negative
Analysts Estimate AptarGroup (ATR) to Report a Decline in Earnings: What to Look Out for
2021-10-21 17:24

AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire
Neutral
Aptar Declares Quarterly Dividend
2021-10-14 17:00

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, today declared a quarterly cash dividend of $0.38 per share. The payment date is November 17, 2021, to stockholders of record as of October 27, 2021. As previously announced, Aptar will hold a conference call on Friday, October 29, 2021 at 8:00 a.m. Central Time to discuss the Company's third quarter results for 2021. The call wi

Zacks Investment Research
Neutral
GEF or ATR: Which Is the Better Value Stock Right Now?
2021-10-11 13:49

GEF vs. ATR: Which Stock Is the Better Value Option?

Loading more news...